This inventor holds 1 USPTO granted patent. Top assignee: Oclassen Pharmaceuticals, Inc.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Karl M Johnson: Innovator in Antiviral Treatments
Introduction
Karl M Johnson is a notable inventor based in Bozeman, MT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral infections. His work focuses on developing effective methods for combating herpes virus strains that are resistant to conventional treatments.
Latest Patents
Karl M Johnson holds 1 patent for his invention titled "Methods for treatment with compositions effective against." This patent relates to pharmaceutical compositions that are useful for treating subjects suffering from infections caused by herpes virus strains resistant to acyclovir. His research has revealed that low dosage amounts of 1-(2'-deoxy-2'-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (FIAU) can effectively inhibit the replication of acyclovir-resistant HSV strains. The invention also encompasses methods for preparing these antiviral compositions and their application in treating infections.
Career Highlights
Karl M Johnson is associated with Oclassen Pharmaceuticals, Inc., where he continues to advance his research in antiviral treatments. His innovative approach has the potential to significantly impact the pharmaceutical industry and improve treatment options for patients suffering from resistant viral infections.
Collaborations
Throughout his career, Karl has collaborated with esteemed colleagues, including Dennis W Adair and Earl R Kern. These partnerships have fostered a collaborative environment that enhances the development of effective antiviral therapies.
Conclusion
Karl M Johnson's contributions to antiviral treatments exemplify the importance of innovation in addressing medical challenges. His work not only advances scientific knowledge but also offers hope for improved patient outcomes in the fight against resistant viral infections.